• LAST PRICE
    8.2100
  • TODAY'S CHANGE (%)
    Trending Down-0.4200 (-4.8667%)
  • Bid / Lots
    8.2000/ 11
  • Ask / Lots
    8.2300/ 5
  • Open / Previous Close
    8.5600 / 8.6300
  • Day Range
    Low 8.1000
    High 8.6899
  • 52 Week Range
    Low 2.8900
    High 10.5484
  • Volume
    251,079
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 8.63
TimeVolumePDSB
09:32 ET17928.55
09:33 ET37218.57
09:35 ET10008.6394
09:37 ET10008.6072
09:39 ET8008.56
09:42 ET11758.5
09:44 ET19008.565
09:46 ET10508.51
09:48 ET113288.46
09:50 ET16338.44
09:51 ET13008.41
09:53 ET35508.3925
09:55 ET44738.3475
09:57 ET26008.33
10:00 ET12008.3899
10:02 ET45068.39
10:04 ET20008.3964
10:06 ET31058.37
10:08 ET90128.42
10:09 ET29518.38
10:11 ET22378.33
10:13 ET77388.2827
10:15 ET32508.2755
10:18 ET71948.37
10:20 ET38828.36
10:22 ET2008.34
10:24 ET23318.31
10:26 ET25908.28
10:27 ET79008.25
10:29 ET35008.305
10:31 ET2508.3
10:33 ET2508.3
10:36 ET7508.26
10:38 ET49878.19
10:40 ET138198.1826
10:42 ET8008.2176
10:44 ET1008.2
10:45 ET48218.185
10:47 ET20008.22
10:49 ET12508.24
10:51 ET10008.2299
10:54 ET42008.19
10:56 ET55728.18
10:58 ET1008.2141
11:00 ET50868.2
11:02 ET2808.2199
11:03 ET25788.18
11:05 ET15938.16
11:07 ET18008.185
11:09 ET17758.14
11:12 ET13768.17
11:14 ET3458.1946
11:16 ET12008.16
11:18 ET21008.11
11:20 ET28868.15
11:21 ET29398.1
11:23 ET4628.13
11:25 ET8008.17
11:27 ET15778.17
11:30 ET11008.15
11:32 ET10008.16
11:34 ET32658.1999
11:36 ET39228.24
11:38 ET6008.21
11:39 ET65878.24
11:41 ET2008.23
11:43 ET11188.19
11:45 ET14288.18
11:48 ET13008.14
11:50 ET15138.18
11:52 ET19008.23
11:54 ET26318.23
11:56 ET1008.207
11:57 ET54348.24
11:59 ET1008.23
12:03 ET10008.2152
12:06 ET25968.255
12:14 ET13508.24
12:15 ET6308.25
12:17 ET1218.25
12:24 ET12278.22
12:26 ET1008.22
12:28 ET15008.22
12:30 ET12008.22
12:32 ET36258.2634
12:33 ET14068.21
12:35 ET12408.21
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPDSB
PDS Biotechnology Corp
246.0M
-8.1x
---
United StatesVAXX
Vaxxinity Inc
244.5M
-3.5x
---
United StatesTHRX
Theseus Pharmaceuticals Inc
247.8M
-5.5x
---
United StatesTERN
Terns Pharmaceuticals Inc
244.1M
-3.1x
---
United StatesFENC
Fennec Pharmaceuticals Inc
252.1M
-11.8x
---
United StatesABOS
Acumen Pharmaceuticals Inc
258.6M
-5.1x
---
As of 2022-11-29

Company Information

PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is engaged in the developing a pipeline of molecularly targeted immunotherapies. The Company owns the T-cell activating platforms designed to train the immune system to attack and destroy disease; Versamune, for treatments in oncology and Infectimune, for treatments in infectious disease. Infectimune is also designed to promote the induction of disease-specific neutralizing antibodies. Its immuno-oncology product candidates are of potential interest for use as a component of combination product candidates to provide treatments across a range of advanced and/or refractory cancers. It develops targeted product candidates to treat several cancers, including Human Papillomavirus (HPV) associated cancers, melanoma, colorectal, lung, breast and prostate cancers. Its infectious disease candidates are of potential interest as vaccines to prevent COVID-19 and universal influenza.

Contact Information

Headquarters
25B Vreeland Road, Suite 300FLORHAM PARK, NJ, United States 07932
Phone
---
Fax
908-790-1212

Executives

Independent Chairman of the Board
Stephen Glover
President, Chief Executive Officer, Director
Frank Bedu-Addo
Chief Financial Officer and Principal Financial and Accounting Officer
Matthew Hill
Senior Vice President, General Counsel
Spencer Brown
Senior Vice President - Business Development
Sanjay Zaveri

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$246.0M
Revenue (TTM)
$0.00
Shares Outstanding
28.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.60
EPS
$-1.01
Book Value
$2.22
P/E Ratio
-8.1x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.